ADIPOQ and metabolic syndrome: Adiponectin enhances basal glucose and insulin-stimulated glucose uptake in adipose tissues via AMPK activation and its levels demonstrated an inverse correlation with adiposity and proinflammatory cytokines in patients suffering from metabolic syndrome [37,38].